Sunday, May 11, 2025
Home 2021 July

Monthly Archives: July 2021

Biotech News

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety...

Editor / Curator -
ehave, ehvvf
All News

Ehave (EHVVF) Looks to Power the Psychedelics Revolution

Editor / Curator -
All News

Whistleblowers Make Millions (Video).

Editor / Curator -
Psychedelic Stock Review
Psychedelic Stock Review

Ehave (EVVHF) Hires Institutional Review Board (IRB) As It Solidifies Partnership...

Editor / Curator -
Psychedelic Stock Review
Investor Conference

Psychedelic Investor Conferences.

Editor / Curator -
Biotech News

Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.

Editor / Curator -
Marijuana Stock Review

Nextleaf’s (OILFF) Cannabis Industry IP Strategy.

Editor / Curator -
Psychedelic Stock Review
Psychedelic News

Psychedelic Primer Guide. (Psychedelic Medicine Association)

Editor / Curator -
Greenbrook Health
Psychedelic Stock Review

Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.

Editor / Curator -
@bryteeyes3
Biotech News

Citius (CTXR). Dang Flippers!

Editor / Curator -
12Page 2 of 2

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.